Considering its diverse cellular functions and seemingly opposite roles in malignancies arising from the gastrointestional tract (tissues rich in epithelial components) compared to cancers in the other parts of the body (tissues rich in mesenchymal components), it can be speculated that S100A14 is involved in a wide range of signaling pathways with a considerable variation in the outcome. This evidence concerns the gene S100A14 and cancer.